Skip to main content
OpenTrials

Clinical trial condition

Metastatic ER+ Her2- Breast Cancer

Explore clinical trials studying Metastatic ER+ Her2- Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Metastatic ER+ Her2- Breast Cancer trial results

Completed

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

NCT01381874

Conditions
Breast Diseases, Breast Neoplasms, Metastatic ER+ Her2- Breast Cancer, +9 more
Locations
  • Muscle Shoals, Alabama, United States
  • Fresno, California, United States
  • Los Angeles, California, United States
  • Monterey, California, United States
View all 81 locations
View Trial Details

Related conditions